X4 Pharmaceuticals, Inc. (XFOR)
4.24
-0.11
(-2.53%)
USD |
NASDAQ |
Apr 02, 16:00
4.23
-0.01
(-0.24%)
After-Hours: 20:00
X4 Pharmaceuticals Shareholders Equity (Quarterly) : 186.29M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Immuneering Corp. | 218.48M |
| Tango Therapeutics, Inc. | 346.18M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 290.46M |
| Total Liabilities (Quarterly) | 104.17M |
| Debt to Equity Ratio | 0.4149 |
| Current Ratio | 10.15 |
| Net Debt Paydown Yield | 0.05% |